EU Approves AstraZeneca-Oxford Vaccine for All Adults Amid Shortfall
- Germany sticks with recommendation for 18- to 64-year-olds
- EMA cites lack of data for elderly but says vaccine effective
This article is for subscribers only.
The European Union’s drug regulator cleared a Covid-19 vaccine from AstraZeneca Plc and the University of Oxford for all adults as a shortfall in expected deliveries raises tensions between the company and the bloc.
The go-ahead Friday clears the way for the European Commission to issue a conditional marketing authorization. The Astra-Oxford vaccine will be the third available in the EU after shots from Pfizer Inc. and Moderna Inc., and it could help alleviate the shortage of shots as the EU trails the U.K. and the U.S. in vaccinations.